| COVID‑19 and its consequences on mental health K Tsamakis, D Tsiptsios, A Ouranidis, C Mueller, D Schizas, C Terniotis, ... Experimental and therapeutic medicine 21 (3), 1-1, 2021 | 203 | 2021 |
| Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis I Mykoniatis, N Pyrgidis, I Sokolakis, A Ouranidis, P Sountoulides, ... JAMA network open 4 (2), e2036337-e2036337, 2021 | 50 | 2021 |
| mRNA therapeutic modalities design, formulation and manufacturing under pharma 4.0 principles A Ouranidis, T Vavilis, E Mandala, C Davidopoulou, E Stamoula, ... Biomedicines 10 (1), 50, 2021 | 43 | 2021 |
| Complexation of single stranded RNA with an ionizable lipid: an all-atom molecular dynamics simulation study AN Rissanou, A Ouranidis, K Karatasos Soft Matter 16 (30), 6993-7005, 2020 | 30 | 2020 |
| The effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews N Pyrgidis, I Mykoniatis, AB Haidich, M Tirta, P Talimtzi, D Kalyvianakis, ... Frontiers in Pharmacology 12, 735708, 2021 | 26 | 2021 |
| Sildenafil 4.0—Integrated synthetic chemistry, formulation and analytical strategies effecting immense therapeutic and societal impact in the fourth industrial era A Ouranidis, A Tsiaxerli, E Vardaka, CK Markopoulou, CK Zacharis, ... Pharmaceuticals 14 (4), 365, 2021 | 24 | 2021 |
| Pharma 4.0 continuous mRNA drug products manufacturing A Ouranidis, C Davidopoulou, RK Tashi, K Kachrimanis Pharmaceutics 13 (9), 1371, 2021 | 23 | 2021 |
| Association between sleep insufficiency and dyslipidemia: a cross-sectional study among Greek adults in the primary care setting D Tsiptsios, E Leontidou, PN Fountoulakis, A Ouranidis, A Matziridis, ... Sleep Science 15 (S 01), 49-58, 2022 | 16 | 2022 |
| Overcoming the solubility barrier of ibuprofen by the rational process design of a nanocrystal formulation A Ouranidis, N Gkampelis, E Vardaka, A Karagianni, D Tsiptsios, ... Pharmaceutics 12 (10), 969, 2020 | 15 | 2020 |
| Graphene-wrapped copper nanoparticles: an antimicrobial and biocompatible nanomaterial with valuable properties for medical uses V Vasilopoulos, M Pitou, I Fekas, R Papi, A Ouranidis, E Pavlidou, ... ACS omega 5 (41), 26329-26334, 2020 | 13 | 2020 |
| Development of a nanocrystal formulation of a low melting point api following a quality by design approach A Ouranidis, N Gkampelis, C Markopoulou, I Nikolakakis, K Kachrimanis Processes 9 (6), 954, 2021 | 12 | 2021 |
| Association of antipsychotic use with raised eosinophil count K Tsamakis, C Mueller, I Hortis, M Kallergi, I Tolos, E Alevyzakis, ... Experimental and therapeutic medicine 21 (5), 1-5, 2021 | 10 | 2021 |
| Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analyses N Pyrgidis, I Mykoniatis, AB Haidich, M Tirta, P Talimtzi, D Kalyvianakis, ... BMJ open 11 (8), e047396, 2021 | 9 | 2021 |
| Biopharmaceutics 4.0, advanced pre-clinical development of mRNA-encoded monoclonal antibodies to immunosuppressed murine models A Ouranidis, T Choli-Papadopoulou, ET Papachristou, R Papi, ... Vaccines 9 (8), 890, 2021 | 8 | 2021 |
| Pharma 4.0-artificially intelligent digital twins for solidified nanosuspensions C Davidopoulou, A Ouranidis Pharmaceutics 14 (10), 2113, 2022 | 7 | 2022 |
| Sleep insufficiency and incident diabetes mellitus among indigenous and minority populations in Greece A Matziridis, D Tsiptsios, A Manolis, A Ouranidis, AS Triantafyllis, ... Sleep Science 14 (S 02), 101-110, 2021 | 7 | 2021 |
| Development of agomelatine nanocomposite formulations by wet media milling E Vardaka, A Ouranidis, I Nikolakakis, K Kachrimanis European Journal of Pharmaceutical Sciences 166, 105979, 2021 | 6 | 2021 |
| COVID‑19 and its consequences on mental health (Review). Exp. Ther. Med. 21, 1–1 K Tsamakis, D Tsiptsios, A Ouranidis, C Mueller, D Schizas, C Terniotis, ... | 6 | 2021 |
| Age and gender effects on the association of sleep insufficiency with hypertension among adults in Greece D Tsiptsios, A Matziridis, A Ouranidis, AS Triantafyllis, A Terzoudi, ... Future Cardiology 17 (8), 1381-1393, 2021 | 5 | 2021 |
| Integrating Elastic Tensor and Pc-Saft Modeling with Systems-Based Pharma 4.0 Simulation, to Predict Process Operations and Product Specifications of Ternary Nanocrystalline … A Ouranidis, C Davidopoulou, K Kachrimanis Pharmaceutics 13 (11), 1771, 2021 | 5 | 2021 |
